Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Alexander Fleming Cancer Institute (Instituto Alexander Fleming) is a premier private medical institution located in Buenos Aires, Argentina, dedicated exclusively to oncology. Founded in 1994, it has become a reference center in Latin America for the prevention, diagnosis, and treatment of various cancer types. The institute integrates high-complexity clinical care with a strong emphasis on scientific research and medical education through its affiliation with the FUCA foundation. Its multidisciplinary teams provide advanced therapies including immunotherapy, targeted molecular therapy, and precision radiotherapy. As a major clinical research site, the institute participates in numerous international multicenter trials, contributing to the development of new oncological drugs. The facility is equipped with state-of-the-art technology for diagnostic imaging and pathology, ensuring a comprehensive approach to patient management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alexander Fleming Cancer Institute.